Foundation Medicine to Present at Upcoming Investor Conferences

Feb 26, 2014

Foundation Medicine to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine, Inc. (NASDAQ:FMI) today announced that members of the company's management team will present at the following upcoming investor conferences:

  • Steven J. Kafka, Ph.D., chief operating officer, will present at the Cowen 34th Annual Health Care Conference on Tuesday, March 4, 2014 at 8 a.m. ET in Boston.
  • Jason Ryan, senior vice president, finance, will present at the 26th Annual ROTH Conference on Monday, March 10, 2014 at 3 p.m. PT in Dana Point, Calif.

Live, listen-only webcasts of the presentations can be accessed by visiting the investors section of the Foundation Medicine website at A replay of each webcast will be available shortly after the conclusion of the presentation and archived on the company's website for two weeks following each presentation.

About Foundation Medicine

Foundation Medicine® (NASDAQ: FMI) is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company's clinical assays, FoundationOneTM for solid tumors and FoundationOneTM Heme for hematologic malignancies, sarcomas and pediatric cancers, each provide a fully informative genomic profile to identify the molecular alterations in a patient's tumor and match them with relevant targeted therapies and clinical trials. Foundation Medicine's molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. For more information, please visit or follow Foundation Medicine on Twitter (@FoundationATCG).

Foundation Medicine® is a registered trademark, and FoundationOneTM is a trademark, of Foundation Medicine, Inc.

Media Contact:
Pure Communications, Inc.
Dan Budwick, 973-271-6085
Investor Contact:
Matt Clawson, 617-418-2283

Source: Foundation Medicine

News Provided by Acquire Media